Skip to main content
EDEN RESEARCH PLC logo

EDEN RESEARCH PLC — Investor Relations & Filings

Ticker · EDEN ISIN · GB0001646941 LEI · 213800ZWTYTVQQSM3J85 IL Manufacturing
Open in API
Filings indexed 350 across all filing types
Latest filing 2024-06-10 Board/Management Inform…
Country GB United Kingdom
Listing IL EDEN

About EDEN RESEARCH PLC

https://www.edenresearch.com/

Eden Research plc develops and supplies sustainable biopesticides and plastic-free encapsulation technologies. The company's core innovation is its proprietary Sustaine® microencapsulation system, which protects and delivers naturally occurring, plant-based active ingredients known as terpenes. Its products serve three primary markets: crop protection, animal health, and consumer products. The crop protection portfolio includes the biofungicide Mevalone® and the bionematicide Cedroz®, designed for applications such as foliar disease control, soil pest management, and post-harvest treatments. In animal health and consumer goods, its technologies are used in products like shampoos, flea and tick control, deodorants, and head-lice treatments.

Recent filings

Filing Released Lang Actions
Appointment of Global Commercial Lead
Board/Management Information Classification · 99% confidence The document is identified by the header 'RNS Number : 7843R' and concludes with the statement 'This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' The content announces the 'Appointment of Global Commercial Lead,' which is a material event concerning senior management changes. This type of announcement, distributed via the Regulatory News Service (RNS), fits best under the general 'Regulatory Filings' category (RNS) as it is not a specific financial report (like 10-K or ER) or a specific management change report (like DEF 14A for remuneration). Since it is a standard, non-prescribed regulatory announcement distributed through the RNS system, RNS is the most appropriate classification.
2024-06-10 English
Publication of Annual Report and Notice of AGM
Regulatory Filings Classification · 98% confidence The document is an official announcement released via RNS (RNS Number: 2842R) on June 5, 2024. The title explicitly states: "Publication of Annual Report and Notice of AGM". It informs shareholders that the Annual Report and Accounts for the year ended 31 December 2023 AND the Notice of the Annual General Meeting ("AGM") have been issued and are available on the website. Since the document's primary function is to announce the publication of two key documents (Annual Report and AGM Notice) rather than containing the full content of the Annual Report (10-K) or the detailed proxy materials (DEF 14A/PSI), it fits best under the category for announcing report publications. Given the dual nature (Annual Report publication + AGM Notice), the most appropriate classification is Report Publication Announcement (RPA), as it is an announcement about reports being released. If the document were the full Annual Report, it would be 10-K. If it were only the AGM details, it might lean towards AGM-R or PSI, but here it is explicitly announcing the publication of the Annual Report and the AGM Notice together. RPA covers the act of publishing reports.
2024-06-05 English
Group of companies' accounts made up to 2023-12-31
Regulatory Filings
2024-06-05 English
Corporate Presentation
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number header and contains a date stamp typical of regulatory news service announcements. The core content announces that an 'Updated Corporate Presentation' (specifically, a 'new 2023 Preliminary Results Presentation') is now available to view on the Company's website ahead of an Investor Meet Company event. This structure—announcing the availability of a presentation or report without containing the full report itself—fits the definition of a Report Publication Announcement (RPA). It is not the Investor Presentation (IP) itself, but the announcement of its publication. Since RPA is a specific category for this type of announcement, it is preferred over the general fallback RNS.
2024-05-15 English
Investor Presentation via Investor Meet Company
Report Publication Announcement Classification · 99% confidence The document is an announcement from Eden Research plc, identified by the RNS Number and the London Stock Exchange context. The core content announces that the CEO and CFO will provide a live presentation to investors via the 'Investor Meet Company' platform on a future date (May 16, 2024). This is not a full financial report (like 10-K or IR), nor is it a transcript of a call that has already happened. It is an announcement about an upcoming investor event, which aligns best with the 'Investor Presentation' category, even though the presentation itself hasn't occurred yet. The closest matching category is 'Investor Presentation' (IP), as it is directly promoting an upcoming presentation to investors.
2024-05-09 English
Appointment of Non-Executive Director
Board/Management Information Classification · 98% confidence The document is identified by the header 'RNS Number : 2718N' and concludes with standard RNS disclaimers, indicating it is a regulatory announcement distributed via the London Stock Exchange's RNS service. The content explicitly announces the 'Appointment of Non-Executive Director' and details the director's background and future role (Chairman of the Audit Committee). This type of announcement, concerning changes in senior management/board composition, directly maps to the 'Board/Management Information' category (MANG). It is not a full financial report (10-K, IR), a proxy statement (DEF 14A), or a general regulatory filing fallback (RNS), as MANG is more specific.
2024-05-07 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.